Can Purdue Pharma’s opioid settlement win judge’s approval?
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off remains to be seen, especially with about half the states opposed to the deal.